My primary clinical focus is on pediatric neuromuscular disorders. My research investigates the implementation of earlier interventions (such as gene therapies) for pediatric neuromuscular disorders (particularly Duchenne muscular dystrophy), to assess long-term outcomes through the development and quantification of novel therapeutic treatments such as electrical impedance myography and magnetic resonance imaging and spectroscopy. The multi-disciplinary approach of our Duchenne Program allows for the ability to comprehensively and thoroughly provide the best care possible to all of our patients.